Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$15.3 - $20.24 $7,940 - $10,504
-519 Reduced 99.62%
2 $0
Q4 2023

Jan 30, 2024

SELL
$11.94 - $20.47 $788 - $1,351
-66 Reduced 11.24%
521 $10,000
Q3 2023

Oct 25, 2023

SELL
$16.3 - $22.09 $3,162 - $4,285
-194 Reduced 24.84%
587 $9,000
Q2 2023

Aug 07, 2023

SELL
$19.41 - $23.43 $3,882 - $4,686
-200 Reduced 20.39%
781 $16,000
Q1 2023

May 08, 2023

BUY
$18.06 - $25.27 $17,716 - $24,789
981 New
981 $19,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.17B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.